IO-202,Venetoclax
Immune-Onc Therapeutics,Roche,Abbvie
['leukemia', 'congrat']
congrats to and #startup company on progress with potential leukemia drug discovered by drs. zhiqiang an and philipp scherer. #innovation 
OTM is responsible for licensing and commercializing cutting edge research developed at UTHealth.  Please contact us at  invent@uth.tmc.edu